Thailand has been warned by the European Commission against moves to force drugmakers to drop prices for poor patients or lose sales, adding to US pressure over patent protection.

Peter Mandelson, the trade commissioner, has written to Bangkok to protest against its consideration of a broad use of compulsory licences, allowing it to import cheaper generic versions of branded medicines produced by western companies.